nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCB1—melanoma	0.214	1	CbGaD
Apixaban—ABCG2—Vemurafenib—melanoma	0.147	0.222	CbGbCtD
Apixaban—ABCG2—Dactinomycin—melanoma	0.0977	0.148	CbGbCtD
Apixaban—CYP1A2—Carmustine—melanoma	0.0767	0.116	CbGbCtD
Apixaban—CYP1A2—Vemurafenib—melanoma	0.0606	0.0917	CbGbCtD
Apixaban—CYP3A4—Temozolomide—melanoma	0.0579	0.0877	CbGbCtD
Apixaban—ABCG2—Docetaxel—melanoma	0.0504	0.0763	CbGbCtD
Apixaban—CYP1A2—Dacarbazine—melanoma	0.0464	0.0703	CbGbCtD
Apixaban—ABCB1—Dactinomycin—melanoma	0.0352	0.0533	CbGbCtD
Apixaban—CYP3A4—Vemurafenib—melanoma	0.0317	0.0481	CbGbCtD
Apixaban—CYP3A5—Docetaxel—melanoma	0.0279	0.0423	CbGbCtD
Apixaban—ABCB1—Docetaxel—melanoma	0.0182	0.0275	CbGbCtD
Apixaban—CYP3A4—Docetaxel—melanoma	0.0109	0.0165	CbGbCtD
Apixaban—Retinal haemorrhage—Carmustine—melanoma	0.0026	0.0489	CcSEcCtD
Apixaban—Haemorrhage intracranial—Temozolomide—melanoma	0.002	0.0376	CcSEcCtD
Apixaban—Gamma-glutamyltransferase increased—Vemurafenib—melanoma	0.00195	0.0366	CcSEcCtD
Apixaban—Cerebral haemorrhage—Carmustine—melanoma	0.00153	0.0288	CcSEcCtD
Apixaban—Cerebral haemorrhage—Temozolomide—melanoma	0.00148	0.0278	CcSEcCtD
Apixaban—Transaminases increased—Carmustine—melanoma	0.00139	0.0262	CcSEcCtD
Apixaban—Vaginal haemorrhage—Temozolomide—melanoma	0.00111	0.0208	CcSEcCtD
Apixaban—Menorrhagia—Temozolomide—melanoma	0.00111	0.0208	CcSEcCtD
Apixaban—Petechiae—Temozolomide—melanoma	0.000996	0.0187	CcSEcCtD
Apixaban—Gamma-glutamyltransferase increased—Temozolomide—melanoma	0.000996	0.0187	CcSEcCtD
Apixaban—Connective tissue disorder—Vemurafenib—melanoma	0.000792	0.0149	CcSEcCtD
Apixaban—Eye disorder—Vemurafenib—melanoma	0.000753	0.0141	CcSEcCtD
Apixaban—Angiopathy—Vemurafenib—melanoma	0.000731	0.0137	CcSEcCtD
Apixaban—Mediastinal disorder—Vemurafenib—melanoma	0.000726	0.0136	CcSEcCtD
Apixaban—Diabetes mellitus—Carmustine—melanoma	0.000708	0.0133	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.000684	0.0129	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Carmustine—melanoma	0.000616	0.0116	CcSEcCtD
Apixaban—Liver function test abnormal—Dactinomycin—melanoma	0.000607	0.0114	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000593	0.0111	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000592	0.0111	CcSEcCtD
Apixaban—Blood bilirubin increased—Docetaxel—melanoma	0.000576	0.0108	CcSEcCtD
Apixaban—Anaphylactic shock—Vemurafenib—melanoma	0.000572	0.0108	CcSEcCtD
Apixaban—Liver function test abnormal—Carmustine—melanoma	0.000569	0.0107	CcSEcCtD
Apixaban—Nervous system disorder—Vemurafenib—melanoma	0.000561	0.0105	CcSEcCtD
Apixaban—Skin disorder—Vemurafenib—melanoma	0.000556	0.0104	CcSEcCtD
Apixaban—Breast disorder—Temozolomide—melanoma	0.000538	0.0101	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000536	0.0101	CcSEcCtD
Apixaban—Hypotension—Vemurafenib—melanoma	0.000535	0.0101	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Temozolomide—melanoma	0.000525	0.00986	CcSEcCtD
Apixaban—Haematuria—Bleomycin—melanoma	0.000518	0.00974	CcSEcCtD
Apixaban—Gastrointestinal disorder—Vemurafenib—melanoma	0.000494	0.00929	CcSEcCtD
Apixaban—Haemoglobin—Bleomycin—melanoma	0.000491	0.00922	CcSEcCtD
Apixaban—Haemorrhage—Bleomycin—melanoma	0.000488	0.00917	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000455	0.00855	CcSEcCtD
Apixaban—Hepatobiliary disease—Temozolomide—melanoma	0.000434	0.00815	CcSEcCtD
Apixaban—Haemoglobin—Carmustine—melanoma	0.000428	0.00805	CcSEcCtD
Apixaban—Haemorrhage—Carmustine—melanoma	0.000426	0.00801	CcSEcCtD
Apixaban—Hypersensitivity—Vemurafenib—melanoma	0.000422	0.00793	CcSEcCtD
Apixaban—Connective tissue disorder—Carmustine—melanoma	0.000419	0.00787	CcSEcCtD
Apixaban—Haemoglobin—Temozolomide—melanoma	0.000414	0.00778	CcSEcCtD
Apixaban—Haemorrhage—Temozolomide—melanoma	0.000412	0.00774	CcSEcCtD
Apixaban—Urinary tract disorder—Temozolomide—melanoma	0.000407	0.00764	CcSEcCtD
Apixaban—Connective tissue disorder—Temozolomide—melanoma	0.000405	0.0076	CcSEcCtD
Apixaban—Urethral disorder—Temozolomide—melanoma	0.000404	0.00759	CcSEcCtD
Apixaban—Eye disorder—Carmustine—melanoma	0.000398	0.00748	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000396	0.00744	CcSEcCtD
Apixaban—Anaemia—Bleomycin—melanoma	0.000393	0.00738	CcSEcCtD
Apixaban—Eye disorder—Temozolomide—melanoma	0.000385	0.00723	CcSEcCtD
Apixaban—Dizziness—Vemurafenib—melanoma	0.000378	0.00711	CcSEcCtD
Apixaban—Angiopathy—Temozolomide—melanoma	0.000374	0.00702	CcSEcCtD
Apixaban—Immune system disorder—Temozolomide—melanoma	0.000372	0.00699	CcSEcCtD
Apixaban—Mediastinal disorder—Temozolomide—melanoma	0.000371	0.00697	CcSEcCtD
Apixaban—Anaemia—Dactinomycin—melanoma	0.000366	0.00688	CcSEcCtD
Apixaban—Liver function test abnormal—Docetaxel—melanoma	0.000365	0.00687	CcSEcCtD
Apixaban—Rash—Vemurafenib—melanoma	0.000361	0.00678	CcSEcCtD
Apixaban—Dermatitis—Vemurafenib—melanoma	0.000361	0.00678	CcSEcCtD
Apixaban—Breast disorder—Docetaxel—melanoma	0.000358	0.00672	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000356	0.0067	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Docetaxel—melanoma	0.000349	0.00656	CcSEcCtD
Apixaban—Anaphylactic shock—Bleomycin—melanoma	0.000347	0.00652	CcSEcCtD
Apixaban—Anaemia—Carmustine—melanoma	0.000343	0.00644	CcSEcCtD
Apixaban—Nausea—Vemurafenib—melanoma	0.00034	0.00639	CcSEcCtD
Apixaban—Thrombocytopenia—Bleomycin—melanoma	0.000339	0.00638	CcSEcCtD
Apixaban—Anaemia—Temozolomide—melanoma	0.000331	0.00623	CcSEcCtD
Apixaban—Hypotension—Bleomycin—melanoma	0.000324	0.00609	CcSEcCtD
Apixaban—Thrombocytopenia—Dactinomycin—melanoma	0.000317	0.00595	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000303	0.0057	CcSEcCtD
Apixaban—Thrombocytopenia—Carmustine—melanoma	0.000296	0.00557	CcSEcCtD
Apixaban—Anaphylactic shock—Temozolomide—melanoma	0.000292	0.0055	CcSEcCtD
Apixaban—Hepatobiliary disease—Docetaxel—melanoma	0.000288	0.00542	CcSEcCtD
Apixaban—Epistaxis—Docetaxel—melanoma	0.000288	0.00541	CcSEcCtD
Apixaban—Nervous system disorder—Temozolomide—melanoma	0.000287	0.00539	CcSEcCtD
Apixaban—Thrombocytopenia—Temozolomide—melanoma	0.000286	0.00538	CcSEcCtD
Apixaban—Skin disorder—Temozolomide—melanoma	0.000284	0.00534	CcSEcCtD
Apixaban—Hypotension—Carmustine—melanoma	0.000283	0.00532	CcSEcCtD
Apixaban—Haemoglobin—Docetaxel—melanoma	0.000275	0.00517	CcSEcCtD
Apixaban—Haemorrhage—Docetaxel—melanoma	0.000274	0.00515	CcSEcCtD
Apixaban—Urinary tract disorder—Docetaxel—melanoma	0.00027	0.00508	CcSEcCtD
Apixaban—Connective tissue disorder—Docetaxel—melanoma	0.000269	0.00506	CcSEcCtD
Apixaban—Urethral disorder—Docetaxel—melanoma	0.000268	0.00504	CcSEcCtD
Apixaban—Gastrointestinal disorder—Carmustine—melanoma	0.000261	0.00491	CcSEcCtD
Apixaban—Eye disorder—Docetaxel—melanoma	0.000256	0.00481	CcSEcCtD
Apixaban—Hypersensitivity—Bleomycin—melanoma	0.000255	0.0048	CcSEcCtD
Apixaban—Gastrointestinal disorder—Temozolomide—melanoma	0.000253	0.00475	CcSEcCtD
Apixaban—Angiopathy—Docetaxel—melanoma	0.000248	0.00467	CcSEcCtD
Apixaban—Immune system disorder—Docetaxel—melanoma	0.000247	0.00465	CcSEcCtD
Apixaban—Mediastinal disorder—Docetaxel—melanoma	0.000247	0.00464	CcSEcCtD
Apixaban—Hypersensitivity—Dactinomycin—melanoma	0.000238	0.00448	CcSEcCtD
Apixaban—Hypersensitivity—Carmustine—melanoma	0.000223	0.00419	CcSEcCtD
Apixaban—Anaemia—Docetaxel—melanoma	0.00022	0.00414	CcSEcCtD
Apixaban—Rash—Bleomycin—melanoma	0.000219	0.00411	CcSEcCtD
Apixaban—Dermatitis—Bleomycin—melanoma	0.000218	0.00411	CcSEcCtD
Apixaban—Hypersensitivity—Temozolomide—melanoma	0.000215	0.00405	CcSEcCtD
Apixaban—Syncope—Docetaxel—melanoma	0.000214	0.00402	CcSEcCtD
Apixaban—Loss of consciousness—Docetaxel—melanoma	0.000209	0.00394	CcSEcCtD
Apixaban—Nausea—Bleomycin—melanoma	0.000206	0.00387	CcSEcCtD
Apixaban—Rash—Dactinomycin—melanoma	0.000204	0.00383	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000201	0.00379	CcSEcCtD
Apixaban—Dizziness—Carmustine—melanoma	0.0002	0.00376	CcSEcCtD
Apixaban—Anaphylactic shock—Docetaxel—melanoma	0.000195	0.00366	CcSEcCtD
Apixaban—Dizziness—Temozolomide—melanoma	0.000193	0.00364	CcSEcCtD
Apixaban—Nausea—Dactinomycin—melanoma	0.000192	0.00361	CcSEcCtD
Apixaban—Shock—Docetaxel—melanoma	0.000191	0.0036	CcSEcCtD
Apixaban—Rash—Carmustine—melanoma	0.000191	0.00359	CcSEcCtD
Apixaban—Nervous system disorder—Docetaxel—melanoma	0.000191	0.00359	CcSEcCtD
Apixaban—Dermatitis—Carmustine—melanoma	0.000191	0.00358	CcSEcCtD
Apixaban—Thrombocytopenia—Docetaxel—melanoma	0.00019	0.00358	CcSEcCtD
Apixaban—Skin disorder—Docetaxel—melanoma	0.000189	0.00355	CcSEcCtD
Apixaban—Rash—Temozolomide—melanoma	0.000184	0.00347	CcSEcCtD
Apixaban—Dermatitis—Temozolomide—melanoma	0.000184	0.00346	CcSEcCtD
Apixaban—Hypotension—Docetaxel—melanoma	0.000182	0.00342	CcSEcCtD
Apixaban—Nausea—Carmustine—melanoma	0.00018	0.00338	CcSEcCtD
Apixaban—Nausea—Temozolomide—melanoma	0.000174	0.00327	CcSEcCtD
Apixaban—Gastrointestinal disorder—Docetaxel—melanoma	0.000168	0.00316	CcSEcCtD
Apixaban—Hypersensitivity—Docetaxel—melanoma	0.000143	0.00269	CcSEcCtD
Apixaban—Dizziness—Docetaxel—melanoma	0.000129	0.00242	CcSEcCtD
Apixaban—Rash—Docetaxel—melanoma	0.000123	0.00231	CcSEcCtD
Apixaban—Dermatitis—Docetaxel—melanoma	0.000123	0.0023	CcSEcCtD
Apixaban—Nausea—Docetaxel—melanoma	0.000116	0.00217	CcSEcCtD
Apixaban—CYP1A2—Metabolism—PLCB4—melanoma	1.71e-05	0.000238	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—SLC5A5—melanoma	1.71e-05	0.000237	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CUBN—melanoma	1.68e-05	0.000234	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	1.68e-05	0.000234	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SDHD—melanoma	1.66e-05	0.000232	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CSPG4—melanoma	1.66e-05	0.000232	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—BSG—melanoma	1.66e-05	0.000232	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GNAQ—melanoma	1.65e-05	0.000229	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CD44—melanoma	1.65e-05	0.000229	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PHGDH—melanoma	1.63e-05	0.000227	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—LUM—melanoma	1.63e-05	0.000227	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.63e-05	0.000227	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SDHD—melanoma	1.62e-05	0.000226	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—BSG—melanoma	1.62e-05	0.000226	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CSPG4—melanoma	1.62e-05	0.000226	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GPAM—melanoma	1.61e-05	0.000225	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIP4K2A—melanoma	1.61e-05	0.000224	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC6A11—melanoma	1.61e-05	0.000224	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HPSE—melanoma	1.6e-05	0.000223	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—VCAN—melanoma	1.59e-05	0.000222	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP1B1—melanoma	1.58e-05	0.00022	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GPAM—melanoma	1.57e-05	0.000219	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CUBN—melanoma	1.57e-05	0.000219	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MTAP—melanoma	1.57e-05	0.000218	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PTEN—melanoma	1.54e-05	0.000215	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.54e-05	0.000215	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PLA2G6—melanoma	1.54e-05	0.000214	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.53e-05	0.000213	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CSPG4—melanoma	1.52e-05	0.000211	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—BSG—melanoma	1.52e-05	0.000211	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SDHD—melanoma	1.52e-05	0.000211	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.5e-05	0.000209	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GPAM—melanoma	1.47e-05	0.000205	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.47e-05	0.000204	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.47e-05	0.000204	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.4e-05	0.000194	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PHGDH—melanoma	1.4e-05	0.000194	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—LUM—melanoma	1.4e-05	0.000194	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.39e-05	0.000193	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—VCAN—melanoma	1.38e-05	0.000192	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PLA2G6—melanoma	1.37e-05	0.000191	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HPSE—melanoma	1.37e-05	0.000191	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP17A1—melanoma	1.34e-05	0.000187	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CUBN—melanoma	1.34e-05	0.000187	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PLA2G6—melanoma	1.34e-05	0.000186	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLCB4—melanoma	1.32e-05	0.000184	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.31e-05	0.000182	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ABCB1—melanoma	1.3e-05	0.000181	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SDHD—melanoma	1.3e-05	0.000181	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—BSG—melanoma	1.3e-05	0.000181	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CSPG4—melanoma	1.3e-05	0.000181	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.27e-05	0.000177	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GNA11—melanoma	1.27e-05	0.000177	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.26e-05	0.000176	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GPAM—melanoma	1.26e-05	0.000175	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PLA2G6—melanoma	1.25e-05	0.000174	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC6A11—melanoma	1.24e-05	0.000173	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIP4K2A—melanoma	1.24e-05	0.000173	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—FASN—melanoma	1.24e-05	0.000173	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—VCAN—melanoma	1.23e-05	0.000171	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.23e-05	0.000171	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—SLC5A5—melanoma	1.22e-05	0.00017	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MTAP—melanoma	1.21e-05	0.000168	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—VCAN—melanoma	1.2e-05	0.000167	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PRKCA—melanoma	1.2e-05	0.000167	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ERCC2—melanoma	1.19e-05	0.000165	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CD44—melanoma	1.18e-05	0.000164	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GNAQ—melanoma	1.18e-05	0.000164	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.17e-05	0.000162	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP17A1—melanoma	1.16e-05	0.000162	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.15e-05	0.00016	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.13e-05	0.000158	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP1B1—melanoma	1.13e-05	0.000158	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.13e-05	0.000157	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—VCAN—melanoma	1.12e-05	0.000156	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GNA11—melanoma	1.1e-05	0.000153	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PIK3CA—melanoma	1.09e-05	0.000152	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—LUM—melanoma	1.08e-05	0.00015	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PHGDH—melanoma	1.08e-05	0.00015	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—FASN—melanoma	1.08e-05	0.00015	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PLA2G6—melanoma	1.07e-05	0.000149	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.06e-05	0.000148	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—SLC5A5—melanoma	1.06e-05	0.000147	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HPSE—melanoma	1.06e-05	0.000147	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.04e-05	0.000145	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP17A1—melanoma	1.04e-05	0.000145	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CUBN—melanoma	1.04e-05	0.000144	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.03e-05	0.000143	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.02e-05	0.000143	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GNAQ—melanoma	1.02e-05	0.000142	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CD44—melanoma	1.02e-05	0.000142	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP17A1—melanoma	1.01e-05	0.000141	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.01e-05	0.000141	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CSPG4—melanoma	1e-05	0.000139	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—BSG—melanoma	1e-05	0.000139	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SDHD—melanoma	1e-05	0.000139	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1e-05	0.000139	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.92e-06	0.000138	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GNA11—melanoma	9.81e-06	0.000137	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP1B1—melanoma	9.8e-06	0.000136	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GPAM—melanoma	9.7e-06	0.000135	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—FASN—melanoma	9.6e-06	0.000134	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—VCAN—melanoma	9.6e-06	0.000134	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GNA11—melanoma	9.58e-06	0.000133	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP17A1—melanoma	9.47e-06	0.000132	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SLC5A5—melanoma	9.44e-06	0.000132	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	9.39e-06	0.000131	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CG—melanoma	9.37e-06	0.000131	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—FASN—melanoma	9.37e-06	0.000131	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.34e-06	0.00013	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ABCB1—melanoma	9.31e-06	0.00013	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	9.22e-06	0.000128	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SLC5A5—melanoma	9.22e-06	0.000128	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GNAQ—melanoma	9.12e-06	0.000127	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CD44—melanoma	9.12e-06	0.000127	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.08e-06	0.000126	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PPARG—melanoma	9.04e-06	0.000126	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GNA11—melanoma	8.95e-06	0.000125	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.93e-06	0.000124	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GNAQ—melanoma	8.9e-06	0.000124	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CD44—melanoma	8.9e-06	0.000124	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—AKT1—melanoma	8.89e-06	0.000124	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.85e-06	0.000123	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.77e-06	0.000122	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—FASN—melanoma	8.75e-06	0.000122	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP1B1—melanoma	8.75e-06	0.000122	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.65e-06	0.00012	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SLC5A5—melanoma	8.61e-06	0.00012	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PRKCA—melanoma	8.57e-06	0.000119	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP1B1—melanoma	8.54e-06	0.000119	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ERCC2—melanoma	8.5e-06	0.000118	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GNAQ—melanoma	8.32e-06	0.000116	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CD44—melanoma	8.32e-06	0.000116	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLA2G6—melanoma	8.24e-06	0.000115	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CD—melanoma	8.24e-06	0.000115	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.14e-06	0.000113	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ALB—melanoma	8.13e-06	0.000113	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP17A1—melanoma	8.1e-06	0.000113	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.07e-06	0.000112	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ABCB1—melanoma	8.07e-06	0.000112	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.98e-06	0.000111	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP1B1—melanoma	7.97e-06	0.000111	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	7.88e-06	0.00011	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.72e-06	0.000107	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GNA11—melanoma	7.65e-06	0.000106	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—FASN—melanoma	7.48e-06	0.000104	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PRKCA—melanoma	7.43e-06	0.000103	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—VCAN—melanoma	7.41e-06	0.000103	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ERCC2—melanoma	7.36e-06	0.000103	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC5A5—melanoma	7.36e-06	0.000102	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ABCB1—melanoma	7.2e-06	0.0001	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CB—melanoma	7.18e-06	0.0001	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS2—melanoma	7.12e-06	9.91e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GNAQ—melanoma	7.11e-06	9.9e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CD44—melanoma	7.11e-06	9.9e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.04e-06	9.8e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.96e-06	9.69e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.9e-06	9.6e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP1B1—melanoma	6.81e-06	9.49e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CG—melanoma	6.71e-06	9.35e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PRKCA—melanoma	6.63e-06	9.23e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ERCC2—melanoma	6.57e-06	9.15e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ABCB1—melanoma	6.57e-06	9.14e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPARG—melanoma	6.48e-06	9.03e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PRKCA—melanoma	6.47e-06	9.01e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ERCC2—melanoma	6.42e-06	8.93e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP17A1—melanoma	6.25e-06	8.7e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTEN—melanoma	6.21e-06	8.64e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.1e-06	8.5e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PRKCA—melanoma	6.04e-06	8.42e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.01e-06	8.38e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ERCC2—melanoma	5.99e-06	8.35e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CD—melanoma	5.9e-06	8.22e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GNA11—melanoma	5.9e-06	8.22e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALB—melanoma	5.83e-06	8.12e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CG—melanoma	5.82e-06	8.1e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—FASN—melanoma	5.77e-06	8.04e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC5A5—melanoma	5.68e-06	7.91e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPARG—melanoma	5.61e-06	7.82e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCB1—melanoma	5.61e-06	7.81e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GNAQ—melanoma	5.49e-06	7.64e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CD44—melanoma	5.49e-06	7.64e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.44e-06	7.58e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP1B1—melanoma	5.26e-06	7.32e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CG—melanoma	5.19e-06	7.23e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PRKCA—melanoma	5.16e-06	7.19e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CB—melanoma	5.15e-06	7.17e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ERCC2—melanoma	5.12e-06	7.13e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CD—melanoma	5.11e-06	7.12e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS2—melanoma	5.1e-06	7.1e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CG—melanoma	5.07e-06	7.06e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALB—melanoma	5.05e-06	7.03e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPARG—melanoma	5.01e-06	6.98e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.96e-06	6.91e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPARG—melanoma	4.89e-06	6.81e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CG—melanoma	4.73e-06	6.59e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPARG—melanoma	4.57e-06	6.36e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CD—melanoma	4.56e-06	6.36e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALB—melanoma	4.51e-06	6.27e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CB—melanoma	4.46e-06	6.21e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CD—melanoma	4.45e-06	6.2e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTEN—melanoma	4.45e-06	6.19e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS2—melanoma	4.42e-06	6.15e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALB—melanoma	4.4e-06	6.12e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CA—melanoma	4.38e-06	6.1e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCB1—melanoma	4.33e-06	6.03e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.24e-06	5.91e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CD—melanoma	4.16e-06	5.8e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALB—melanoma	4.11e-06	5.72e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CG—melanoma	4.04e-06	5.63e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PRKCA—melanoma	3.99e-06	5.55e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CB—melanoma	3.98e-06	5.54e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ERCC2—melanoma	3.95e-06	5.5e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS2—melanoma	3.94e-06	5.49e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPARG—melanoma	3.9e-06	5.44e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CB—melanoma	3.88e-06	5.41e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTEN—melanoma	3.85e-06	5.36e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS2—melanoma	3.85e-06	5.36e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CB—melanoma	3.63e-06	5.05e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS2—melanoma	3.59e-06	5e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AKT1—melanoma	3.58e-06	4.98e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CD—melanoma	3.56e-06	4.95e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALB—melanoma	3.51e-06	4.89e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTEN—melanoma	3.44e-06	4.79e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTEN—melanoma	3.35e-06	4.67e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CA—melanoma	3.14e-06	4.37e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTEN—melanoma	3.13e-06	4.36e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CG—melanoma	3.12e-06	4.35e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CB—melanoma	3.1e-06	4.32e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS2—melanoma	3.07e-06	4.28e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPARG—melanoma	3.01e-06	4.2e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CD—melanoma	2.74e-06	3.82e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CA—melanoma	2.72e-06	3.78e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALB—melanoma	2.71e-06	3.77e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTEN—melanoma	2.68e-06	3.73e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKT1—melanoma	2.56e-06	3.57e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CA—melanoma	2.42e-06	3.38e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CB—melanoma	2.39e-06	3.33e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS2—melanoma	2.37e-06	3.3e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CA—melanoma	2.37e-06	3.3e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKT1—melanoma	2.22e-06	3.09e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CA—melanoma	2.21e-06	3.08e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTEN—melanoma	2.07e-06	2.88e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKT1—melanoma	1.98e-06	2.76e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKT1—melanoma	1.93e-06	2.69e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CA—melanoma	1.89e-06	2.63e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKT1—melanoma	1.81e-06	2.52e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKT1—melanoma	1.54e-06	2.15e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CA—melanoma	1.46e-06	2.03e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKT1—melanoma	1.19e-06	1.66e-05	CbGpPWpGaD
